You can buy or sell Renalytix and other stocks, options, and ETFs commission-free!
Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom. The listed name for RNLX is Renalytix AI plc American Depositary Shares.
52 Week High
52 Week Low
— per share
Expected Feb 14, Pre-Market